New York State Common Retirement Fund’s Clearside Biomedical CLSD Stock Holding History

New York State Common Retirement Fund’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,340	Closed	-$28K	–	3254
2019 Q1	$28K	Hold	1,340	–	–	﹤0.01%	3116
2018 Q4	$22K	Sell	1,340 -800	-37%	-$37.5K	﹤0.01%	3154
2018 Q3	$197K	Hold	2,140	–	–	﹤0.01%	2832
2018 Q2	$343K	Buy	2,140 +667	+45%	+$112K	﹤0.01%	2619
2018 Q1	$237K	Hold	1,473	–	–	﹤0.01%	2671
2017 Q4	$155K	Hold	1,473	–	–	﹤0.01%	2863
2017 Q3	$193K	Hold	1,473	–	–	﹤0.01%	2795
2017 Q2	$201K	Buy	1,473 +993	+207%	+$119K	﹤0.01%	2836
2017 Q1	$57K	Buy	+480	New	+$56.7K	﹤0.01%	3052

Other funds holding CLSD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

New York State Common Retirement Fund's CLSD Position: Q2 2019 in Review

New York State Common Retirement Fund sold out of Clearside Biomedical (CLSD) in Q2 2019, closing a stake of 1,340 shares — an estimated $28K sold.

New York State Common Retirement Fund first reported a position in CLSD in Q1 2017 and held it in 9 quarters. The position peaked at $343K in Q2 2018. 50 funds tracked by Wall St. Rank hold CLSD as of Q2 2019.

New York State Common Retirement Fund reported no remaining Clearside Biomedical position as of Q2 2019 after selling out during the quarter.
New York State Common Retirement Fund sold 1,340 Clearside Biomedical shares in Q2 2019, an estimated $28K.
New York State Common Retirement Fund first reported a position in Clearside Biomedical in Q1 2017 and held it in 9 quarters.
New York State Common Retirement Fund's Clearside Biomedical position peaked at $343K in Q2 2018.
50 funds tracked by Wall St. Rank held Clearside Biomedical as of Q2 2019.

Based on New York State Common Retirement Fund's 13F filing for Q2 2019, filed 9 Aug 2019.